Nachrichten zur Johnson Matthey PLC Aktie

Why Is Johnson & Johnson (JNJ) Up 13% Since Last Earnings Report?

Johnson & Johnson (JNJ) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

Johnson & Johnson explores $20 billion sale of an orthopedics unit, Bloomberg News reports By Reuters

Johnson & Johnson explores $20 billion sale of an orthopedics unit, Bloomberg News reports…

Johnson & Johnson prepares to sell orthopedics unit for over $20 billion

Johnson & Johnson prepares to sell orthopedics unit for over $20 billion - Bloomberg…

Johnson & Johnson to invest $1B in Pennsylvania manufacturing facility

Johnson & Johnson announced a $1 billion investment in a Montgomery County, Pennsylvania, cell therapy facility that will yield over…

Johnson & Johnson investing $1B to build new cell therapy facility in Montgomery County

Johnson & Johnson is investing more than $1 billion to build a new cell therapy plant in Montgomery County.…

Johnson & Johnson to Invest More Than $1 Billion in Pennsylvania Cell Therapy Factory

The facility is part of the company’s plans to invest $55 billion in U.S. manufacturing, research and development and technology…

J&J to invest $1 billion in new Pennsylvania plant amid US manufacturing push

Johnson & Johnson said on Wednesday it will invest more than $1 billion to build a new cell therapy facility…

Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania

• Advanced manufacturing site will utilize cutting?edge cell therapy technologies to help deliver the company’s portfolio of transformational medicines •…

Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial By Reuters

Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial…

Johnson & Johnson ordered to pay $250,000 in talc powder lawsuit By Investing.com

Johnson & Johnson ordered to pay $250,000 in talc powder lawsuit…

Johnson & Johnson: Starke Pipeline, teure Aktie

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…

3 Earnings Winners Holding Strong in a Range-Bound Market

Market Analysis by covering: Nasdaq 100, S&P 500, Johnson & Johnson, Meta Platforms Inc. Read s Market Analysis on…

Is Johnson & Johnson a Buy, Sell, or Hold in 2026?

This reliable dividend payer may be just what the doctor ordered.…

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy?

Johnson & Johnson is a picture of stability.…

The Zacks Analyst Blog Johnson & Johnson, Netflix, Arista Networks, Omega and AXIL

Johnson & Johnson leads Zacks latest Analyst Blog as new research highlights earnings beats, growth drivers, and risks across major…

Top Stock Reports for Johnson & Johnson, Netflix & Arista Networks

JNJs Q4 beat, Netflixs subscriber surge, and Arista Networks cloud demand highlight why these stocks headline todays top research reports.…

Morgan Stanley upgrades Johnson & Johnson, sees upside on robust drug pipeline

Morgan Stanleys price target implies that shares of Johnson & Johnson could rise another 17%.…

Johnson & Johnson Aktie: Neues Produktportfolio sorgt für Analysten-Upgrade!

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Morgan Stanley:Die Analysten von Morgan Stanley stufen die Aktie von Johnson &…

Johnson & Johnson Aktie: "Top Pick" im Segment der Large-Cap-Biopharmawerte

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Guggenheim Securities:Guggenheim-Analyst Vamil Divan habe das Kursziel für die Aktie von Johnson…

Johnson & Johnson Aktie: Solide Basis für langfristige Anleger

Frankfurt (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von XTB:Die Experten von XTB nehmen die Aktie der Johnson & Johnson (J&J) (ISIN:…

Johnson & Johnson Aktie: Überraschend starke Zahlen - Startet jetzt die nächste Rally?

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von TD Cowen:TD Cowen-Analyst Joshua Jennings habe das Kursziel für die Aktie von…

Johnson & Johnson Aktie: Starkes Setup - Kommt jetzt das nächste Top-Jahr für die Aktie?

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Goldman Sachs:Goldman-Sachs-Analyst Asad Haider habe das Kursziel für die Aktie von Johnson…

Johnson & Johnson Aktie: Zweistelliges Wachstum im Visier!

San Francisco (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Wells Fargo Advisors:Wells Fargo habe das Kursziel für die Aktie von Johnson…

Johnson & Johnson Aktie: Solide Q4-Zahlen - aber jetzt kommt der Bewertungs-Haken

Charlotte (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von BofA Securities:BofA-Analyst Jason Gerberry habe das Kursziel für die Aktie von Johnson &…

Johnson & Johnson Aktie: Q4-Überraschung und ein Plan für zweistelliges Wachstum!

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Morgan Stanley:Morgan-Stanley-Analyst Terence Flynn habe das Kursziel für die Aktie von Johnson…

Gewinn- sowie Umsatzwachstum bei Johnson & Johnson - Aktien von Netflix und Kraft Heinz unter Druck

Wien (www.aktiencheck.de) - Netflix gab um 2% nach, nachdem die Geschäftszahlen nicht in allen Punkten überzeugen konnten, so die Analysten…

This 2.4%-Yielding Dividend King Remains As Healthy As Ever

Johnson & Johnson had a strong year.…

MDAI: In the Blocks, Ready to Go upon Mid-Year Authorization

By John Vandermosten, CFANASDAQ:MDAIREAD THE FULL MDAI RESEARCH REPORTIt has now been approximately seven months since Spectral AI, Inc. (NASDAQ:MDAI)…

Johnson & Johnson (JNJ) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Johnson & Johnson (JNJ) give a sense of how the business performed in…

Johnson & Johnson (JNJ) Tops Q4 Earnings and Revenue Estimates

Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +1.05% and +1.84%, respectively, for the quarter ended December 2025.…

Market movers: Kraft Heinz, Lisata Therapeutics, Halliburton, Johnson & Johnson...

…

Johnson & Johnson Quartalszahlen Q4: Jahresprognose über Erwartungen

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…

AtaiBeckley seen as key beneficiary of Spravato’s strong growth: Jefferies

Jefferies analysts said the continued commercial momentum of Johnson & Johnson (NYSE:JNJ)s Spravato (esketamine nasal spray) could provide a meaningful...…

Johnson & Johnson forecasts 2026 profit above Wall Street estimates

Johnson & Johnson also reported a fourth-quarter profit ahead of expectations, buoyed by strong sales of the blood cancer therapy…

Johnson & Johnson reports Q4 earnings beat, issues 2026 guidance above forecasts

Johnson & Johnson (NYSE:JNJ) reported fourth quarter and full-year 2025 results that came in above market expectations and issued 2026…

U.S. judge allows experts to testify that talc products cause cancer in J&J cases

In a victory for thousands of women suing Johnson & Johnson over claims that the companys baby powder and…

Robotic surgery fuels Johnson & Johnson dividend growth outlook

Johnson & Johnson (JNJ) just made a move that investors have been waiting years to see. The healthcare heavyweight submitted…

Zacks Investment Ideas feature highlights: Netflix, Intel and Johnson & Johnson

Netflix, Intel and Johnson & Johnson headline Zacks Investment Ideas as key earnings reports approach amid steady estimates.…

Major Earnings Reports Streaming In: Global Week Ahead

The fourth-quarter U.S. earnings season heats up, with reports due from high-profile companies including Netflix (NFLX), Johnson & Johnson (JNJ),…

Tech Still Matters. But It’s a Good Thing More Stocks Are Rallying.

Stocks beyond tech are getting their day in the sun. Stocks like Morgan Stanley, Johnson & Johnson, and Caterpillar are…

Johnson & Johnson (JNJ) Beats Stock Market Upswing: What Investors Need to Know

Johnson & Johnson (JNJ) closed the most recent trading day at $209.72, moving +2.61% from the previous trading session.…

Johnson & Johnson (JNJ) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

…

Johnson & Johnson Aktie: Comeback für Healthcare 2026?

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Sanford C. Bernstein:Bernstein-Analyst Lee Hambright habe das Kursziel für die Aktie von…

Johnson & Johnson reaches deal with US government to lower drug prices

Johnson & Johnson said on Thursday it has reached a agreement with U.S. President Donald Trumps administration to cut drug…

Top Analyst Reports for Johnson & Johnson, Caterpillar and Qualcomm

JNJ is leaning on Innovative Medicine growth and MedTech momentum to offset the Stelara patent cliff as it heads into…

Covid-19: Bayer verklagt Biontech und Pfizer wegen Patenten für Impfstoffe

Der Pharmakonzern Bayer wirft Pfizer, Biontech und Moderna vor, bei ihren Covid-19-Impfstoffen eine patentierte mRNA-Technologie der Bayer-Tochter Monsanto genutzt zu…

Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $204.31, denoting a -1.47% move from…

Johnson & Johnson Aktie: Diese Medikamente könnten jetzt für den nächsten Schub sorgen!

London (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Barclays:Barclays habe das Kursziel für die Aktie von Johnson & Johnson (J&J) (ISIN:…

Apogee Therapeutics Aktie: J&J-Flop öffnet Tür für APG279

New York (www.aktiencheck.de) - Apogee Therapeutics-Aktienanalyse von BTIG:Die Analysten von BTIG haben das "buy"-Rating für die Aktie von Apogee Therapeutics…